筛查性数字乳腺断层摄影假阴性原因的多读者研究
单中心回顾性收集2019年3月至2023年12月所有假阴性筛查数字乳腺断层摄影检查,7名乳腺放射科医师独立复审活检前的筛查与诊断性乳腺摄影。117例女性中,47.9%为漏诊癌,26.5%为乳腺摄影隐匿癌,25.6%为真间期癌,三者在病理特征上存在差异。
要点
- 假阴性筛查中近半数(47.9%)为可显示的漏诊癌,提示阅片环节仍有改进空间。
- 约四分之一(26.5%)为乳腺摄影隐匿癌,更多为T0期且经MRI检出,患者更年轻。
- 真间期癌更常见ER/PR阴性,生物学行为更具侵袭性。
关键影像表现/征象
- 多数假阴性癌在筛查后中位237天(IQR 187-301天)出现症状,共88/117(75.2%)。
- 乳腺摄影隐匿癌更多为T0期(32.3% vs 漏诊癌7.1% vs 真间期癌10.0%)。
- 乳腺摄影隐匿癌更多经MRI检出(48.4% vs 3.6% vs 10.0%),且患者更年轻(51 vs 62 vs 59岁)。
诊断标准与关键数值
- 癌灶分类标准:乳腺摄影隐匿癌(乳腺摄影不可见)、漏诊癌(筛查乳腺摄影可见)、真间期癌(仅诊断性乳腺摄影可见)。
- 真间期癌ER阴性率50.0%(15/30),高于隐匿癌16.1%(5/31)和漏诊癌21.8%(12/55)。
- 真间期癌PR阴性率66.7%(20/30),高于隐匿癌22.6%(7/31)和漏诊癌35.7%(20/56)。
临床应用与阅片要点
- 阅片时应警惕可显示的漏诊癌,约占假阴性的一半,需系统性回顾以减少漏诊。
- 对乳腺摄影阴性但临床可疑或致密乳腺患者,可考虑补充MRI以检出隐匿癌。
- 真间期癌更多为ER/PR阴性,提示其生物学侵袭性较强,随访中需关注新发症状。
局限性
- 单中心回顾性设计,结果外推需谨慎。
- 样本量有限(117例),部分亚组分析统计效能可能不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To classify the causes and pathologic characteristics of false-negative screening digital breast tomosynthesis examinations. Materials and Methods All false-negative screening examinations at a single center from March 1, 2019, through December 31, 2023, were collected. Seven fellowship-trained breast radiologists independently reviewed the false-negative screening and diagnostic mammograms preceding biopsy. For each mammogram, radiologists recorded the cancer as visible or not visible. Cancers were classified as mammographically occult (not visible on mammogram), missed (visible on screening mammogram), or true interval cancers (visible on diagnostic mammogram only). Between-classification comparisons were performed with the Pearson χ2 test or analysis of variance. Results A total of 117 female patients (median age, 60 years [IQR, 49-70 years]) with false-negative screening mammograms were included. Most cancers manifested symptomatically (88 of 117, 75.2%) a median of 237 days (IQR, 187-301 days) after screening mammography. Among cancers, 47.9% (56 of 117), 26.5% (31 of 117), and 25.6% (30 of 117) were missed, mammographically occult, and true interval cancers, respectively. True interval cancers were more often estrogen receptor- (50.0% [15 of 30] vs 16.1% [five of 31] vs 21.8% [12 of 55]) and progesterone receptor-negative (66.7% [20 of 30] vs 22.6% [seven of 31] vs 35.7% [20 of 56]) than mammographically occult and missed cancers. Mammographically occult cancers were more often stage T0 (32.3% [10 of 31] vs 7.1% [four of 56] vs 10.0% [three of 30]) and detected at MRI (48.4% [15 of 31] vs 3.6% [two of 56] vs 10.0% [three of 30]) and developed in younger female patients (51 vs 62 vs 59 years of age, all P < .05) than missed and true interval cancers. Conclusion Half of false-negative screening mammograms were missed, one-quarter were true interval, and one-quarter were mammographically occult cancer, with differences in pathologic characteristics. Keywords: Mammography, Screening © RSNA, 2026 See also the commentary by Elahi and Slanetz in this issue.
引用
- Grimm LJ, Wells V, Baker JA, et al. Causes of False-Negative Screening Digital Breast Tomosynthesis Examinations: A Multireader Study. Radiol Imaging Cancer. 2026. PMID: 42825662. doi:10.1148/rycan.260212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。